Boehringer Ingelheim Kg

Jorge C Stenzel

Albrecht Harreus

Gerhard Walther

Karl-Heinz Weber

Gojko Muacevic

Werner Stransky

Wolf-Dietrich Bechtel

Wolfgang Troger

The invention relates to new 1,4-diazepines of the general formula ##STR1## in which R.sub.1, R.sub.2 R.sub.3, X and A have the meaning indicated in the specification. The new compounds are intended for use for the treatment of pathological states and diseases in which PAF (platelet activating factor) is involved.

Substituted-1,4-diazepines

The invention relates to new thieno-traizolo-1,4-diazepino-2-carboxylic acid amides of formula I ##STR1## wherein R.sub.1 represents hydrogen, a C.sub.1 -C.sub.4 straight-chained or branched alkyl which can optionally be substituted by halogen, preferably Cl or Br, or by hydroxy, cyclopropyl, C.sub.1 -C.sub.3 alkoxy, preferably methoxy, or halogen, preferably chlorine or bromine;

Thieno-traizolo-1,4-diazepino-2-carboxylic acid amides

The invention relates to new thieno-1,4-diazepines of general formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.degree., R', Z, X, Y and n have the meanings given in the specification. The new compounds are intended to be used in the treatment of pathological conditions and diseases in which PAF (platelet activating factor) is implicated.

Thieno-1,4-diazepines

Growing community of inventors

Munich, Germany

Jorge C Stenzel